CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.58B
This Quarter Return
+4.98%
1 Year Return
+14.63%
3 Year Return
+71.56%
5 Year Return
+115.62%
10 Year Return
+272.08%
AUM
$3.18B
AUM Growth
+$3.18B
(+4.9%)
Cap. Flow
+$42.8M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
29.32%
Holding
281
New
14
Increased
110
Reduced
113
Closed
19
Top Buys
| 1 |
S&P Global
SPGI
|
$33.5M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$24.7M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$18.2M |
| 4 |
Hilton Worldwide
HLT
|
$17.6M |
| 5 |
Amphenol
APH
|
$11.7M |
Top Sells
| 1 |
PepsiCo
PEP
|
$27.3M |
| 2 |
JPMorgan Diversified Return International Equity ETF
JPIN
|
$22.9M |
| 3 |
iShares Biotechnology ETF
IBB
|
$13.3M |
| 4 |
SPDR Gold Trust
GLD
|
$9.09M |
| 5 |
Oracle
ORCL
|
$7.86M |
Sector Composition
| 1 | Technology | 21.31% |
| 2 | Financials | 17.07% |
| 3 | Healthcare | 11.16% |
| 4 | Consumer Discretionary | 8.28% |
| 5 | Communication Services | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
CBRE Group
CBRE
$47.2B
| $3.79M | 0.12% |
47,886
-644
| -1% | -$50.9K |
|
102
Exxon Mobil
XOM
$477B
| $3.43M | 0.11% |
61,454
+1,121
| +2% | +$62.6K |
|
103
Emerson Electric
EMR
$73.3B
| $3.42M | 0.11% |
37,926
+13
| +0% | +$1.17K |
|
104
Ultragenyx Pharmaceutical
RARE
$3.08B
| $3.41M | 0.11% |
29,908
-1,100
| -4% | -$125K |
|
105
iShares Morningstar US Equity ETF
ILCB
$1.1B
| $3.31M | 0.1% |
14,752
-821
| -5% | -$184K |
|
106
iShares Core S&P Mid-Cap ETF
IJH
$99.5B
| $3.15M | 0.1% |
12,114
+225
| +2% | +$58.6K |
|
107
Morgan Stanley
MS
$238B
| $3.06M | 0.1% |
39,350
+26,989
| +218% | +$2.1M |
|
108
iShares Russell 1000 Growth ETF
IWF
$117B
| $3.05M | 0.1% |
12,552
-680
| -5% | -$165K |
|
109
Vanguard Short-Term Bond ETF
BSV
$38.3B
| $2.96M | 0.09% |
36,017
-8,569
| -19% | -$704K |
|
110
IBM
IBM
$225B
| $2.81M | 0.09% |
21,107
+45
| +0.2% | +$6K |
|
111
Tesla
TSLA
$1.1T
| $2.78M | 0.09% |
4,163
+391
| +10% | +$261K |
|
112
Wells Fargo
WFC
$260B
| $2.63M | 0.08% |
67,245
-1,441
| -2% | -$56.3K |
|
113
iShares MSCI Emerging Markets ETF
EEM
$19B
| $2.5M | 0.08% |
46,892
+741
| +2% | +$39.5K |
|
114
Boston Scientific
BSX
$159B
| $2.4M | 0.08% |
62,109
-813
| -1% | -$31.4K |
|
115
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$1.98B
| $2.35M | 0.07% |
60,972
+2,625
| +4% | +$101K |
|
116
Goldman Sachs Innovate Equity ETF
GINN
$232M
| $2.28M | 0.07% |
39,820
-68
| -0.2% | -$3.89K |
|
|
117
Oracle
ORCL
$630B
| $2.19M | 0.07% |
31,202
-111,973
| -78% | -$7.86M |
|
118
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.5B
| $2.02M | 0.06% |
36,998
-5,401
| -13% | -$295K |
|
119
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.22B
| $1.86M | 0.06% |
14,491
-94
| -0.6% | -$12.1K |
|
|
120
SPDR Gold Trust
GLD
$111B
| $1.84M | 0.06% |
11,492
-56,807
| -83% | -$9.09M |
|
121
AT&T
T
$205B
| $1.75M | 0.05% |
57,675
-10,259
| -15% | -$311K |
|
122
Intel
INTC
$105B
| $1.72M | 0.05% |
26,945
-1,863
| -6% | -$119K |
|
123
SPDR S&P Biotech ETF
XBI
$5.31B
| $1.72M | 0.05% |
12,701
+2,874
| +29% | +$390K |
|
124
Hexcel
HXL
$5.15B
| $1.68M | 0.05% |
30,000
| – | – |
|
125
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.04B
| $1.68M | 0.05% |
21,368
-200
| -0.9% | -$15.7K |
|